DPC-681

CAS No. 284661-68-3

DPC-681 ( DPH-153893 )

Catalog No. M13867 CAS No. 284661-68-3

A potent and selective inhibitor of HIV-1 protease with IC90 of 4-40 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 514 Get Quote
50MG 1962 Get Quote
100MG 2520 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    DPC-681
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent and selective inhibitor of HIV-1 protease with IC90 of 4-40 nM.
  • Description
    A potent and selective inhibitor of HIV-1 protease with IC90 of 4-40 nM; showes no loss in potency towardrecombinant mutant HIVs with the D30N mutation and a fivefold or smaller loss in potency toward mutant variants with three to five amino acid substitutions.
  • Synonyms
    DPH-153893
  • Pathway
    Microbiology/Virology
  • Target
    HIV
  • Recptor
    HIV
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    284661-68-3
  • Formula Weight
    669.85
  • Molecular Formula
    C35H48FN5O5S
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    CC(C)(C)[C@@H](C(N)=O)N(C(CNCC1=CC=CC(F)=C1)=O)[C@@H](CC2=CC=CC=C2)[C@H](O)CN(S(=O)(C3=CC=CC(N)=C3)=O)CC(C)C
  • Chemical Name
    L-Valinamide, N-[(3-fluorophenyl)methyl]glycyl-N-[(1S,2R)-3-[[(3-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-3-methyl-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kaltenbach RF 3rd, et al. Antimicrob Agents Chemother. 2001 Nov;45(11):3021-8.
2. Solon EG, et al. Drug Metab Dispos. 2002 Nov;30(11):1164-9.
molnova catalog
related products
  • TAK-779

    TAK-779 is a potent, specific, nonpeptide CCR5 antagonist with Kd of 0.45 nM.

  • MK-8591

    MK-8591 (Islatravir, MK8591, EFdA) is a nucleoside analog that exhibits remarkable potency against wild-type and drug-resistant HIVs.

  • ABX464

    ABX464 (ABX-464, ABX 464) is a novel class of anti-HIV small molecule targeting Rev-mediated viral RNA biogenesis.